An empowering writing experience will leave you with a sense you have spent time meaningfully.
Academic rigor, journalistic flair
Articles on COVID-19
Displaying 2381 - 2400 of 7973 articles
With youth ages 12 and over eligible for COVID-19 vaccination — and as trials for younger children move ahead — parental hesitancy is emerging as the new challenge for COVID-19 vaccine programs.
Simulations of classrooms and offices can help determine the safest configurations to reduce the spread of COVID-19.
When public art pairs artistic expression with community engagement, it can honour the diverse communities that share public spaces and spur important conversations.
The written word has guided us through distance from our loved ones for centuries. Here’s how it can bring us closer
How well are the Tokyo Olympics prepared for a COVID crisis when there is still an outbreak in the country, the vaccination rates are low and athletes are asked to socially distance?
Two international law scholars explain the history of the ‘right to enter’ provision and how this applies to Australians stuck overseas.
We know that the COVID pandemic has increased economic inequality around the world - here’s how children understand, and respond to, other people having much more than others.
For those desperate for international holidays, there is light at the end of the tunnel.
An effective regional approach to combating COVID-19 has seen Africa avoid the worst so far.
Even when we immunise all Australians who want to be protected against COVID-19, we’re unlikely to achieve herd immunity through vaccination alone. We need three other measures to open our borders.
South Africa has clearly suffered the consequences of poor strategic decisions to this point. It doesn’t need to continue along these lines.
An AI analysis shows that differences in how New Yorkers and Angelenos tweet go beyond the words they use.
There’s a way for parents to spot the fraud.
The question of whether we should be vaccinating children and adolescents against COVID-19 is currently being debated. Here’s why the answer is ‘not yet’.
Delta plus might reduce the efficacy of the vaccines currently in use. But we can’t be sure because we’re yet to see good data on this variant.
Medical receptionists have taken on new roles during the pandemic, which no-one planned for. We must not forget them and the stressful work they do.
The messages people under 60 have been getting about the AstraZeneca vaccine this week have been confusing, to say the least. Experts say to consider the risks and benefits. But how do you do this?
AstraZeneca, Pfizer and Moderna appear equivalent in reducing your chance of serious illness from COVID-19.
The nice way to describe a new study suggesting lockdowns haven’t saved lives is that it’s ‘brave’.
Top contributors
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Senior Research Fellow in Global Health, University of Southampton
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Medicine, University of East Anglia
-
Associate Professor, School of Population Health, UNSW Sydney
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Public Health, University of Sheffield
-
Professor of Medicine, University of Virginia
